Sign In
test

Nathan Fischel

Dafna Capital Management Llc

Assets Managed
$439.592M
Holdings
83
Last Quarter
2026 - Q1
Filed Date
1d ago
Growth Rate
2.11%(2Q avg: 4.24%)
Sustained Growth
4 quarters

Portfolio positions

This chart displays the top 10 holdings in Dafna Capital Management Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 83 positions.

Assets under management

The assets under management (AUM) of Dafna Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 439.592M in assets, with a quarterly growth rate of 2.11% and a 2-quarter average growth rate of 4.24%. The portfolio is managed by Nathan Fischel, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
RVMD
Revolution Medicines Inc
Recent Activity
Decreased -3.94%
12.85%
$56.471M
580,678 shares@ $97.26 avg price
XBI
Spdr S&p Biotech Etf
Recent Activity
Decreased -5.34%
9.26%
$40.683M
318,505 shares@ $127.74 avg price
STXS
Stereotaxis Inc
Recent Activity
5.73%
$25.172M
13.681M shares@ $1.84 avg price
DAWN
Day One Biopharmaceuticals I
Recent Activity
Decreased -2.07%
4.78%
$20.978M
978,463 shares@ $21.45 avg price
ATRC
Atricure Inc
Recent Activity
3.88%
$17.045M
597,431 shares@ $28.53 avg price
IDYA
Ideaya Biosciences Inc
Recent Activity
Decreased -5.92%
3.62%
$15.885M
476,740 shares@ $33.33 avg price
XENE
Xenon Pharmaceuticals Inc
Recent Activity
Decreased -12.9%
3.32%
$14.582M
250,772 shares@ $58.16 avg price
CYTK
Cytokinetics Inc
Recent Activity
Decreased -41.37%
3.27%
$14.335M
217,497 shares@ $65.91 avg price
CMPS
Compass Pathways Plc
Recent Activity
Increased 198.25%
3.05%
$13.376M
2.419M shares@ $5.53 avg price
NKTR
Nektar Therapeutics
Recent Activity
Increased 120.25%
2.71%
$11.885M
165,178 shares@ $71.95 avg price

1-10 of 83